Home
NHLBI-CONNECTS Common Data Elements (CDE)
COVID-19 Therapeutic Trial Common Data Elements
PhenX URL:
Resource Type:
Guideline
Contact:
Availability:
Publicly Available, No Cost
Common Data Elements:
Yes
Date Published:
12/16/2020
Date Record Updated:
09/09/2021
Description:
This document describes recommended data elements for all therapeutic clinical trials for COVID-19. With the multitude of COVID-19 research being conducted, a common set of data elements is essential for efficiency in the study design process, increased power for discovery through aggregated data, and improved accountability for generalizability and reproducibility. This set of data common data elements (CDEs) is being developed in collaboration with the NHLBI-CONNECTS Study Design Core and NHLBI-funded research networks such as SIREN and PETAL. Trials funded through NHLBI-CONNECTS will implement these CDEs and make their data available through NHLBI's BioData Catalyst data access and compute environment.
Content Adapted From:
Additional Descriptors
- Administered By:
- Self
- Administration Mode:
- Online or Mobile App
- Language:
- English
- Number of Survey Questions :
- 100+
- Resource Type:
- Guideline
- Study Population:
- General
- Age: Adult
- Age: Adult
- Event Type:
- Infectious Disease Outbreak
- Exposure Agent:
- Biological or Infectious Agent
- Biological or Infectious Agent: Virus
- Virus: SARS-CoV-2, SARS-CoV-1, MERS
- Virus: SARS-CoV-2, SARS-CoV-1, MERS
- Biological or Infectious Agent: Virus
- Special Topics:
- Demographics, Diagnosis or Status or Treatment or Recovery, Risk Reduction Behaviors, Symptoms
- Risk Reduction Behaviors: Vaccine-related
Files within the Disaster Research Response (DR2) Resources Portal may not be 508-compliant. If you need help accessing a specific file please contact dr2@niehs.nih.gov. NIEHS is working to make all files fully accessible and conformant.